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Abstract: We evaluated the relationship between glucose abnormalities and periodontitis in overweight/obese individuals. Eight hundred and seventy (870) diabetes-free participants aged 40–65 years
completed the three-year follow-up in the San Juan Overweight Adults Longitudinal Study. The
ADA thresholds for fasting and 2-h post-load glucose and HbA1c were used to define prediabetes.
The NHANES methods were used to assess periodontitis. Multivariable linear regression was used
to evaluate the relationship between baseline glucose metabolism measures and periodontitis at
follow-up, adjusting for potential confounders. There was no association between impaired glucose
measures and mean pocket depth (PD), mean clinical attachment loss (CAL), or mean percent of
sites ≥5 mm PD. Impaired glucose tolerance (IGT) was associated with a lower mean percent of sites
≥5 mm CAL (β = −1.6, p = 0.037). Prediabetes and impaired fasting glucose (IFG) were associated
with improvement in mean percent of sites ≥5 mm PD (β = −1.4, p = 0.022; β = −1.6, p = 0.032;
respectively). IFG and IGT were associated with improvement in mean percent of sites with ≥5 mm
CAL (β = −1.6, p = 0.038; β = −1.9, p = 0.020; respectively). In conclusion, there were no consistent
associations between baseline prediabetes or insulin resistance and periodontitis progression over a
three-year period.
Keywords: periodontal disease; pre-diabetic state; insulin resistance; obesity; cohort study
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1. Introduction
The literature to date suggests that the relationship between periodontitis and diabetes
is bidirectional [1]. Periodontal pathogens activate cytokines associated with increased
levels of inflammatory markers and endothelial dysfunction, and altered lipid metabolism,
which could lead to increased glucose abnormalities, insulin resistance, and increased risk
of type 2 diabetes [1,2]. On the other hand, the hyperglycemic state in diabetes is associated
with activated innate immunity, higher levels of inflammatory cytokines, expression of
adhesion molecules, and production and accumulation of advanced glycation end products,
which can contribute to periodontal tissue destruction [1,2].
A few large, longitudinal studies have evaluated the association between diabetes [3–8]
and risk of periodontal disease and have found positive associations. Self-reported diabetes
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has also been associated with a significantly increased risk of self-reported periodontitis
or tooth loss among male participants of the Health Professionals Follow-Up Study [6].
A systematic review of prospective cohort studies concluded that diabetes is associated
with an increased risk of periodontitis onset or progression (RR = 1.86, 95% CI: 1.3–2.8) [9].
However, several methodological caveats were identified in these studies, including a short
follow-up period, a small sample size, and the use of the Community Periodontal Index,
which is a poor measure of periodontal disease.
Data relating pre-clinical stages of type 2 diabetes with periodontal disease have
largely come from several cross-sectional studies [10–19]. Some cross-sectional studies have
found no associations [10,20–22]. Only two large [3,23] and one small [24] longitudinal
studies found associations between prediabetes and insulin resistance with periodontitis or
gingival/periodontal inflammation. Three additional longitudinal studies [25–27] found
that individuals with metabolic syndrome had a higher risk of incident or progression of
periodontitis or tooth loss. However, Nascimento et al. [28] found no association between
the metabolic syndrome components and several periodontitis measures.
Given the inconsistent findings and limited longitudinal data, the San Juan Overweight
Adults Longitudinal Study (SOALS) was initiated to improve our understanding of the
relationship between precursors of type 2 diabetes and periodontitis, and to evaluate
potential mediators of the relationship.
2. Materials and Methods
2.1. Data Source and Study Population
SOALS enrolled a convenience sample in 2011 and included evaluations at baseline
and after a three-year follow-up period. Details about recruitment and retention have been
previously reported [19,29,30]. Briefly, individuals aged 40–65 years who were overweight
or obese (body mass index (BMI) ≥ 25 kg/m2 ), and free of clinically diagnosed diabetes
were recruited from the San Juan municipality area in Puerto Rico. Exclusion criteria
consisted mainly of factors precluding a valid periodontal exam (e.g., less than four teeth,
orthodontic appliances) and factors that may put participants at risk (e.g., cardiovascular
conditions and bleeding disorders). Out of the 1206 participants without diagnosed diabetes
enrolled, 255 did not complete the follow-up. A total of 951 completed the follow-up visit
(79% retention rate), of which 81 were further excluded for missing data; thus, our final
analytical sample consisted of 870 participants (Figure 1). This study was approved by
the human subject ethics board of the University of Puerto Rico Medical Sciences Campus
[UPR Institutional Review Board (IRB), approved on 7 February 2010, IRB #A4840109]
and was conducted in accordance with the Helsinki Declaration of 1975, as revised in
2013. Informed consent was obtained from all participants prior to performance of the
study procedures.
2.2. Definition of Periodontitis as Outcome of the Study
Full mouth periodontal examinations were carried out at baseline (2011) and after
three years of follow-up (2014). The National Health and Nutrition Examination Survey
(NHANES) protocol for periodontitis assessment was used in both baseline and follow-up
assessments [31,32] and performed by one of three calibrated dental examiners [19,29,30].
Periodontitis was assessed by clinical measurements of pocket depth (PD) and gingival
recession at six sites per tooth for all teeth, except the third molars. PD was measured
between the base of the sulcus or the pocket and the free gingival margin (FGM), and
gingival recession was measured between the FGM and the cemento-enamel junction (CEJ)
to compute the clinical attachment loss (CAL). Periodontitis was evaluated as mean PD,
mean CAL, mean percentage of sites with PD ≥ 5 mm, and mean percentage of sites
with CAL ≥ 5 mm at follow-up. Three-year changes in these measures were assessed as
follow-up measure minus baseline measure, with positive values indicating worsening of
PD and CAL and negative values indicating improvement over the three years. For quality
assurance, 40 participants were evaluated by two of the three examiners at baseline and
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follow-up to assess reliability. Using information from all examiners, the pooled intra-class
correlation coefficients using inter-proximal sites for mean CAL was 0.89 (95% CI: 0.81, 0.94)
for
Dent. J. 2022, 10, x FOR PEER REVIEWand for mean PD was 0.93 (95% CI: 0.88, 0.96). All examiners were in perfect agreement
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(CEJ) to compute the clinical attachment loss (CAL). Periodontitis was evaluated as mean
PD, mean CAL, mean percentage of sites with PD ≥ 5 mm, and mean percentage of sites
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assay coefficient of variation = 4.42%). HbA1c was assessed by a latex immunoagglutination
inhibition methodology with monoclonal antibody using a Siemens Kit for DCA 2000 and
DCA Vantage Analyzer. Using the American Diabetes Association (ADA) [33] criteria,
participants without diagnosed diabetes mellitus who were not taking antihyperglycemic
medications were classified as having type 2 diabetes mellitus if they had fasting glucose
≥126 mg/dL, 2hPG ≥ 200 mg/dL, or HbA1c ≥ 6.5%, or prediabetes if they had impaired
fasting glucose (IFG, 100–125 mg/dL), impaired glucose tolerance (IGT, 140–199 mg/dL),
or elevated HbA1c (5.7–6.4%). Participants were classified as having normal glycemia if
all these values were below the mentioned thresholds for prediabetes35 . The homeostatic
model assessment of insulin resistance (HOMA-IR) was calculated as [fasting glucose
(mg/dL) × fasting insulin (mg/dL)]/405]. Since there is no consensus on a cut point to
define HOMA-IR, the study population specific 75th percentile was used (≥3.13).
2.4. Ascertainment of Covariates
In-person interviews and physical and laboratory assessments were performed. Information was collected on age, sex, education (less than high school, high school or more),
smoking status (never, past, current), number of cigarettes per week, alcohol consumption
(grams per week), frequency and type of physical activity during a typical week converted
to the metabolic equivalent of task (MET) in hours per week, number of servings per week
of fruits and vegetables, and family history of diabetes. Anthropometric measurements,
including height, weight, and body circumferences (waist and hip), were taken 2–3 times
according to the NHANES procedures and averaged [34]. The number of dental visits
in the past year, frequency of tooth brushing and dental flossing, mouthwash use, and
periodontal treatment during follow-up were recorded. The Silness and Loe Plaque Index,
a measure of oral hygiene status, was assessed at six pre-selected teeth [35].
Blood pressure was taken three times after 1–2 min intervals [36], and the average was
computed. Participants were classified as hypertensive (i.e., reported physician-diagnosed
hypertension, currently taking antihypertensive medications, average SBP ≥ 140 mm Hg
or average DBP ≥ 90 mm Hg at the baseline examination); pre-hypertensive (i.e., average
SBP between 120- and 139-mm Hg or average DBP between 80- and 89-mm Hg); or
normotensive (i.e., an average SBP < 120 mm Hg and average DBP < 80 mm Hg from the
study assessment). High-density lipoprotein cholesterol (HDL-C) and triglycerides levels
were assessed at a local laboratory reference using a commercially available enzymatic
assay (Roche Diagnostics, Indianapolis, IN, USA).
2.5. Statistical Analysis
Baseline demographic and health characteristics were presented by glycemic status
(normoglycemia and prediabetes). Separate multivariable linear regression models were
used to examine the relationship between the exposure (prediabetes, IFG, IGT, elevated
HbA1c, and HOMA-IR) at baseline, and each outcome measure (mean PD, mean CAL, mean
percentage of sites with PD ≥ 5 mm, and mean percentage of sites with CAL ≥ 5 mm),
while controlling for baseline periodontal measures. Similar analyses modeled threeyear changes in mean PD, mean CAL, mean percentage of sites with PD ≥ 5 mm, mean
percentage of sites with CAL ≥ 5 mm, and mean number of teeth as outcome measures.
Baseline potential confounders were selected based on a priori knowledge and the underlying causal model of the hypothesized association between impaired glucose metabolism
measures and periodontitis. The first multivariate model included age, sex, and smoking
accounting for variation in follow-up time [37,38]. The second model additionally adjusted
for education, physical activity, grams of alcohol consumption, waist circumference, fruit
and vegetable intake, plaque index, and baseline periodontal measure (except for three-year
changes in periodontal measures). The level of significance was set at p value < 0.05 and
a 95% confidence interval (CI) was used for the statistical significance of the results. All
statistical analyses were performed using Stata (StataCorp LP, College Station, TX, USA)
for Windows version 15.
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3. Results
3.1. Baseline Characteristics of SOALS Participants According to Glycemic Status
The median follow-up for this cohort was 2.96 years (25th and 75th percentiles:
2.88 years and 3.01 years, respectively). Participants with prediabetes were more likely
to be older (p < 0.001), less likely to be smokers (p = 0.012), had higher waist circumference (p < 0.001), triglycerides (p < 0.001), and glucose (p < 0.001), and had lower HDL-C
(p = 0.013), and more moderate or severe periodontitis (p = 0.037), hypertension (p < 0.001),
and insulin resistance (p < 0.001) compared to participants with normal glucose (Table 1).
Table 1. Baseline characteristics of SOALS participants across glycemic status (n = 870) *.

Age (years)
Male sex
High school education or more
Annual income ≥ $20,000
Smoking
Never
Past smoker
Current smoker
Alcohol intake (grams/day)
Physical activity (METS/week)
Fruit and vegetable intake (servings/week)
Waist circumference (cm)
BMI (kg/m2 )
Plaque index
Periodontitis status
None/Mild
Moderate
Severe
Number of teeth
Number of teeth in categories
25–28
17–24
11–16
4–10
Dentist visits in past 12 months
Tooth brushing more than once day
Dental flossing more than once a day
Any mouthwash use
Periodontal treatment
HDL-C (mg/dL)
Triglycerides (mg/dL)
Blood pressure classification
Normal
Pre-hypertension
Hypertension
Fasting glucose (mg/dL)
2-hr post load glucose (mg/dL)
Fasting insulin (mIU/L)
HbA1c (%)
HOMA-IR

Prediabetes
(n = 492)

Normoglycemia
(n = 378)

p-Value

51.6 ± 6.7
26.6
90.5
47.8

49.1 ± 6.6
26.7
89.4
47.9

<0.001
0.975
0.616
0.973

65.5
18.3
16.3
2.2 ± 5.2
22.5 ± 44.0
7.0 ± 4.0
107.4 ± 14.5
33.8 ± 6.3
0.79 ± 0.60

62.7
14.3
23.0
2.4 ± 6.5
23.4 ± 37.8
7.5 ± 4.1
103.9 ± 13.6
32.5 ± 6.1
0.81 ± 0.60

33.1
43.1
23.8
23.4 ± 4.3

41.5
38.4
20.1
24.1 ± 4.1

48.8
43.3
6.3
1.6
61.2
91.1
40.8
51.8
53.9
47.2 ± 11.9
157.9 ± 90.3

55.3
39.2
4.2
1.3
63.2
92.1
46.3
55.0
61.1
49.3 ± 13.1
129.3 ± 58.2

17.1
30.9
52.0
96.3 ± 8.8
124.5 ± 32.3
12.1 ± 7.5
5.9 ± 0.3
2.9 ± 1.9

29.9
30.2
40.0
87.4 ± 5.8
101.2 ± 19.6
8.5 ± 5.1
5.5 ± 0.2
1.9 ± 1.2

0.012
0.585
0.754
0.084
<0.001
0.003
0.568
0.037
0.026
0.216

0.537
0.598
0.108
0.349
0.032
0.013
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

* Values are presented as mean ± standard deviation or number (%). Abbreviations: BMI, Body mass Index;
HDL-C, high density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostatic model for
insulin resistance.
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3.2. Baseline and Three-Year Follow-Up Mean Pocket Depth and Mean Clinical Attachment Loss
According to Impaired Glucose Metabolism Measures
Mean PD and mean CAL values were 2.1 ± 0.8 mm and 2.0 ± 1.3 mm, respectively,
for those with prediabetes, and 2.0 ± 0.6 mm and 1.8 ± 1.1 mm, respectively, for those with
normoglycemia (Table 2). There were slight improvements in PD and CAL between baseline
and three-year follow-up in most subgroups defined by abnormal glucose measures (e.g.,
difference in mean PD in IFG: p = 0.041; difference in mean PD in HOMA-IR: p = 0.032). The
mean percent of sites with ≥5 mm PD was slightly higher in individuals with prediabetes
(4.2 ± 11.3%) than in those with normoglycemia (3.1 ± 7.8%) (data not shown). Similarly,
the mean percent of sites with ≥5 mm CAL was higher (7.5 ± 15.5%) in individuals with
prediabetes than those with normoglycemia (5.6 ± 11.7%). Changes in mean percent of sites
with ≥5 mm PD and ≥5 mm CAL at baseline and follow-up suggest slight improvements
in PD and CAL in individuals with abnormal glucose measures (data not shown).
Table 2. Mean levels of pocket depth (PD) and clinical attachment loss (CAL) at baseline and
follow-up visits according to impaired glucose metabolism measures.
Mean PD (mm)

Prediabetes
Yes (n = 492)
No (n = 378)
IFG
Yes (n = 183)
No (n = 687)
IGT
Yes (n = 156)
No (n = 714)
Elevated
HbA1c
Yes (n = 496)
No (n = 374)
HOMA-IR
Yes (n = 189)
No (n = 681)

Mean CAL (mm)

Baseline

Follow-Up

p-Value

Baseline

Follow-Up

p-Value

2.1 ± 0.8
2.0 ± 0.6
p = 0.223

2.0 ± 0.7
2.0 ± 0.7
p = 0.995

0.143

2.0 ± 1.3
1.8 ± 1.1
p = 0.042

1.9 ± 1.2
1.8 ± 1.2
p = 0.105

0.553

2.2 ± 0.8
2.0 ± 0.7
p = 0.020

2.0 ± 0.7
2.0 ± 0.7
p = 0.494

0.041

2.1 ± 1.3
1.9 ± 1.2
p = 0.010

2.0 ± 1.2
1.9 ± 1.2
p = 0.110

0.161

2.1 ± 0.7
2.1 ± 0.7
p = 382

2.0 ± 0.6
2.0 ± 0.7
p = 0.846

0.202

2.0 ± 1.1
1.9 ± 1.2
p = 0.600

1.8 ± 0.9
1.9 ± 1.2
p = 0.601

0.139

2.1 ± 0.8
2.1 ± 0.7
p = 0.610

2.0 ± 0.7
2.0 ± 0.7
p = 0.441

0.78

2.0 ± 1.2
1.9 ± 1.1
p = 0.273

1.9 ± 1.2
1.8 ± 1.2
p = 0.171

0.706

2.2 ± 0.9
2.0 ± 0.7
p < 0.001

2.1 ± 0.7
2.0 ± 0.7
p = 0.030

0.032

2.1 ± 1.3
1.9 ± 1.2
p = 0.017

2.0 ± 1.2
1.9 ± 1.2
p = 0.136

0.196

Note: Prediabetes was defined as impaired fasting glucose (IFG, 100–125 mg/dL), impaired glucose tolerance
(IGT, 140–199 mg/dL), or elevated HbA1c (HbA1c, 5.7–6.4%)]. HOMA-IR was defined based on the study
population-specific 75th percentile (≥3.1). Abbreviations: IFG: Impaired fasting glucose; IGT: 2hr-Impaired
Glucose tolerance; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostatic model for insulin resistance.

3.3. Relationship between Baseline Glucose Metabolism Measures and Periodontitis Measures at
Follow-Up
Linear regression models controlled for age, sex, smoking, education, physical activity, alcohol consumption, waist circumference, fruit and vegetable intake, plaque index,
baseline periodontal measure, and follow-up time. Impaired glucose metabolism measures
were not significantly associated with mean PD, mean CAL, and mean percent of sites with
≥5 mm PD at follow-up (Table 3). However, IGT was associated with a lower mean percent
of sites with ≥5 mm CAL (β = −1.64, p = 0.037), while IFG was of borderline significance
(β = −1.4, p = 0.063).
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Table 3. Multivariable linear regression models for the relationship between baseline glucose
metabolism measures and periodontitis measures at follow-up.
Mean PD, mm

Mean CAL, mm

Mean Percent of Sites
with ≥5 mm PD

Mean Percent of Sites
with ≥5 mm CAL

β (SE)

p Value

β (SE)

p Value

β (SE)

p Value

β (SE)

p Value

Prediabetes
Model 1
Model 2
Model 3

0.0 (0.0)
0.0 (0.0)
0.0 (0.0)

0.995
0.645
0.704

0.1 (0.1)
0.0 (0.1)
0.0 (0.1)

0.105
0.761
0.97

−0.1 (0.6)
−0.6 (0.5)
−0.5 (0.5)

0.81
0.244
0.3

0.8 (1.0)
−0.5 (0.6)
−0.8 (0.6)

0.424
0.422
0.203

IFG
Model 1
Model 2
Model 3

0.0 (0.1)
0.0 (0.0)
0.0 (0.1)

0.494
0.309
0.314

0.2 (0.1)
0.0 (0.1)
0.0 (0.1)

0.11
0.577
0.595

0.1 (0.7)
−0.8 (0.6)
−0.8 (0.6)

0.919
0.158
0.164

0.5 (1.2)
−1.5 (0.8)
−1.4 (0.8)

0.7
0.057
0.063

IGT
Model 1
Model 2
Model 3

0.0 (0.1)
0.0 (0.0)
0.0 (0.0)

0.846
0.522
0.585

−0.1 (0.1)
−0.1 (0.1)
0.0 (0.1)

0.6
0.324
0.534

−0.3 (0.7)
−0.4 (0.6)
−0.3 (0.6)

0.679
0.525
0.593

−1.7 (1.3)
−1.9 (0.8)
−1.6 (0.8)

0.192
0.016
0.037

High
HbA1c
Model 1
Model 2
Model 3

0.0 (0.0)
0.0 (0.0)
0.0 (0.0)

0.441
0.963
0.822

0.1 (0.1)
0.0 (0.1)
0.0 (0.1)

0.171
0.385
0.711

−0.8 (0.6)
−0.6 (0.5)
−0.5 (0.5)

0.149
0.221
0.286

0.9 (1.0)
0.2 (0.6)
−0.2 (0.6)

0.379
0.702
0.754

HOMA-IR
Model 1
Model 2
Model 3

0.1 (0.1)
0.0 (0.0)
0.0 (0.0)

0.03
0.622
0.708

0.1 (0.1)
0.0 (0.1)
0.0 (0.1)

0.136
0.833
0.915

0.7 (0.7)
−0.4 (0.6)
−0.3 (0.6)

0.307
0.521
0.637

1.6 (1.2)
−0.3 (0.7)
−0.4 (0.8)

0.182
0.655
0.589

Note: The reference category for prediabetes, IFG, and IGT is normal glycemia; for elevated HbA1c is normal
HbA1c; and for HOMA-IR is the lower three quartiles combined. Model 1: unadjusted model; Model 2 adjusted
for age, sex, smoking, and follow-up time; Model 3 additionally adjusted for education, physical activity (METs),
alcohol consumption (grams/week), waist circumference, fruit and vegetable intake, total number of teeth, plaque
index, and baseline periodontal measure. Abbreviations: IFG: Impaired fasting glucose; IGT: 2hr-Impaired
Glucose tolerance; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostatic model for insulin resistance.

3.4. Relationship between Baseline Impaired Glucose Metabolism Measures with Three-Year
Changes in Periodontitis Measures
Changes in mean PD and mean CAL were not significantly associated with glucose
metabolism measures (Table 4). However, both prediabetes and IFG were associated with
improvement in mean percent of sites with ≥5 mm PD (β = −1.4, p = 0.02; β = −1.6,
p = 0.032; respectively). Improvement in mean percent of sites with ≥5 mm CAL was
associated with both IFG (β = −1.6, p = 0.038) and IGT (β = −1.9, p = 0.020) while its
association with prediabetes was of borderline significance (β = −1.1, p = 0.078). Since
severe periodontitis could lead to tooth loss, especially among individuals aged 40 years
or over [39,40], the change in the mean number of teeth and incident tooth loss during
the follow-up were also evaluated as secondary outcomes. Still, there were no significant
associations (data not shown).
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Table 4. Results from multivariable linear regression models for the relationship between glucose
metabolism measures and three-year changes in periodontitis.
Change in Mean PD
(mm)

Change in Mean CAL
(mm)

Change in Mean Percent
of Sites with ≥5 mm PD

Change in Mean Percent of
Sites with ≥5 mm CAL

β (SE)

p Value

β (SE)

p Value

β (SE)

p Value

β (SE)

p Value

Prediabetes
Model 1
Model 2
Model 3

−0.1 (0.0)
−0.1 (0.0)
−0.1 (0.0)

0.143
0.167
0.177

0.0 (0.1)
0.0 (0.1)
0.0 (0.1)

0.553
0.685
0.465

−1.3 (0.6)
−1.4 (0.6)
−1.4 (0.6)

0.029
0.022
0.022

−1.1 (0.6)
−0.8 (0.7)
−1.1 (0.6)

0.104
0.197
0.078

IFG
Model 1
Model 2
Model 3

−0.1 (0.1)
−0.1 (0.1)
−0.1 (0.1)

0.041
0.071
0.097

−0.1 (0.1)
−0.1 (0.1)
−0.1 (0.1)

0.161
0.337
0.387

−1.7 (0.7)
−1.7 (0.8)
−1.6 (0.7)

0.018
0.025
0.032

−1.9 (0.8)
−1.7 (0.8)
−1.6 (0.8)

0.013
0.031
0.038

IGT
Model 1
Model 2
Model 3

−0.1 (0.1)
−0.1 (0.1)
−0.1 (0.1)

0.202
0.23
0.298

−0.1 (0.1)
−0.1 (0.1)
−0.1 (0.1)

0.139
0.244
0.332

−0.8 (0.8)
−0.8 (0.8)
−0.7 (0.8)

0.323
0.313
0.387

−2.5 (0.8)
−2.1 (0.8)
−1.9 (0.8)

0.003
0.011
0.02

High
HbA1c
Model 1
Model 2
Model 3

0.0 (0.0)
0.0 (0.0)
0.0 (0.0)

0.8
0.801
0.813

0.0 (0.1)
0.0 (0.1)
0.0 (0.1)

0.706
0.727
0.877

−0.6 (0.6)
−0.8 (0.6)
−0.8 (0.6)

0.299
0.214
0.204

0.0 (0.6)
0.0 (0.7)
−0.4 (0.7)

0.992
0.943
0.528

HOMA-IR
Model 1
Model 2
Model 3

−0.1 (0.0)
−0.1 (0.0)
−0.1 (0.1)

0.032
0.031
0.128

−0.1 (0.1)
−0.1 (0.1)
−0.1 (0.1)

0.196
0.225
0.316

−1.4 (0.7)
−1.4 (0.7)
−1.0 (0.8)

0.044
0.056
0.168

−1.0 (0.8)
−0.8 (0.8)
−0.9 (0.8)

0.216
0.273
0.251

Note: The reference category for prediabetes, IFG, and IGT is normal glycemia; for elevated HbA1c is normal
HbA1c; and for HOMA-IR is the lower three quartiles combined. Model 1: unadjusted model; Model 2 adjusted
for age, sex, smoking, and follow-up time; Model 3 additionally adjusted for education, physical activity (METs),
alcohol consumption (grams/week), waist circumference, fruit and vegetable intake (servings/week), total
number of teeth and plaque index. Abbreviations: IFG: Impaired fasting glucose; IGT: 2hr-Impaired Glucose
tolerance; HbA1c, glycosylated hemoglobin; HOMA-IR, homeostatic model for insulin resistance.

Further adjustment for other baseline factors, including visits to a dentist in the past
year, frequency of tooth brushing or flossing, mouthwash use, blood pressure classification,
number of teeth, medications use, and periodontal treatment during follow-up did not
change the associations, and hence were not included in the final models. Subgroup
analyses by smoking status and the number of teeth were conducted for each impaired
glucose metabolism measure (data not shown). The directions of these associations were
consistent across the teeth categories, and there was no apparent effect modification (data
not shown). We also evaluated potential mediators for the associations where impaired
glucose metabolism measures were significantly associated with periodontitis progression.
Potential mediators (HDL-C, LDL-C, and triglycerides) were added to the final models
one at a time, but the effect estimates were essentially similar and found no evidence of
mediation by these factors (data not shown).
4. Discussion
This longitudinal study is among the first to assess standard measures of impaired
glucose metabolism and insulin resistance as risk factors for periodontitis onset or progression. This study does not corroborate a positive association between baseline prediabetes or
insulin resistance and periodontitis progression over three years. These findings were also
independent of major known confounders for the association between glucose metabolism
and periodontitis, other than genetics, which is a limitation in most epidemiologic studies.
The findings were also consistent among non-smokers, indicating that the results were not
due to residual confounding by smoking.
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To date, there have only been a few longitudinal studies ascertaining whether hyperglycemia or insulin resistance is associated with increased risk of periodontal disease
among people without diabetes, and some are limited by the diagnostic criterion used to
assess periodontal disease. Chiu et al. [3] assessed the risk of prediabetes (fasting plasma
glucose ≥100 mg/dL) in relation to periodontal disease, defined as a Community Periodontal Index score ≥ 3, over a five-year follow-up and found that participants with
prediabetes had an elevated risk for periodontal disease (HR = 1.25; 95% CI: 1.00–1.57) after
adjustment for confounders. However, the Community Periodontal Index does not assess
recession or CAL as it is designed to assess PD at two different thresholds, underestimating
periodontal status. Timonen et al. [24] examined the role of insulin resistance and altered
beta-cell function on the four-year development of periodontal disease, defined by the
presence of periodontal pockets (≥ 4 mm deep). However, the sample size was limited,
PD was measured only at four pre-determined sites, and only the PD of the deepest site
on each tooth was recorded, which may have underestimated disease severity. Our team
assessed the role of insulin resistance on the risk of gingival/periodontal inflammation,
as determined by the number of tooth sites with bleeding on probing (BOP) and number
of teeth with PD ≥ 4 mm and BOP [23]. Participants in the highest HOMA-IR tertile at
baseline had a significantly higher number of sites with BOP (RR = 1.19, 95% CI: 1.03–1.36)
and number of teeth with PD ≥ 4 mm and BOP (RR = 1.39, 95% CI: 1.09–1.78) after comprehensive adjustment for confounders. Importantly this study assessed the number of
sites with BOP since this measure indicates the presence of active status (or condition) of
both reversible plaque-induced gingivitis and irreversible periodontitis. In contrast, the
number of teeth with PD ≥ 4 mm and BOP reflects the number of teeth with a possible
active status of periodontitis only [23]. Taken together, these studies support the need to
elucidate the nature of the longitudinal association between impaired glucose metabolism
and periodontitis.
However, our results were not consistent with our previous cross-sectional report
in the same cohort, where we found that impaired glucose metabolism was significantly
associated with severe periodontitis [19] and with other longitudinal studies showing
similar positive associations [3,23,24]. This might be related to the slow rate of periodontal
disease progression rendering to minimal or even no change of this oral disease within three
years [40,41]. A longitudinal study conducted in a Swedish adult population estimated
that the mean annual progression rate over three years was 0.06 mm for all individuals and
varied between 0.04 and 0.07 mm per subject in the different age groups [41]. Whether the
rate of periodontal disease progression over three years varies according to glycemic status
is unclear.
Strengths of the SOALS study are its longitudinal design, a relatively large sample size,
and high-quality data. We used standard measures from fasting glucose, glucose tolerance
tests, insulin, and HbA1c to evaluate precursors of diabetes. In addition, clinical assessment for periodontal measures was conducted using the NHANES oral health assessment
protocol, the gold standard in clinical periodontal examinations, which included six sites
around each tooth. We measured and adjusted for important potential confounders.
Nonetheless, certain limitations need to be considered when interpreting these findings. Our population was limited to overweight and obese adults, and most participants in
our study had at least a high school education, had a dental visit before the baseline visit,
and reported treatment at baseline. These factors may have affected the generalizability of
the findings.
Since obesity is a significant risk factor for diabetes, limiting this high-risk group
may be a possible reason for not seeing positive associations. However, no established
biological pathways explain why the relationship between these two conditions could be
in the opposite direction. We used a non-probability sampling to recruit the study group,
limiting generalizability; however, the non-random sample would not affect the validity of
the associations within this cohort. Moreover, due to logistical reasons, we could not use
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the same examiner at baseline and follow-up for many participants; this may have led to
some random error or bias.
One possible explanation for the inverse longitudinal associations observed in this
study could be that participants who had impaired glucose metabolism at baseline were
informed of their prediabetes and its potential association with the development of periodontitis, which may have motivated the adoption of healthy oral or other lifestyles.
However, when we evaluated changes from baseline to follow-up data, people with prediabetes, compared to those with normoglycemia, did not show more frequent tooth brushing,
flossing, periodontal treatment, dental visits in the past year, higher reduction in plaque
scores, lipids, or inflammatory markers, nor a higher increase in physical activity over the
follow-up period. These factors could reduce the risk of periodontitis. However, we did not
evaluate changes in the oral microbiome, which could indicate a shift from more putative
bacteria, causing an inflammatory response, to fewer putative bacteria.
In summary, this three-year follow-up study does not show consistent associations
nor supports the hypothesis that prediabetes or IR is associated with PD progression
in overweight/obese adults. In fact, the present study showed some non-significant
improvement of pocket depth and significant improvement of clinical attachment loss
rather than loosing attachment, which might have been related to change in lifestyles. Note,
however, that PD may remain inactive or stable and without periodontal bleeding, while
gingival recession continues to occur without being aware of it, which leads to continuous
loss of attachment, and ultimately tooth loss.
Further research with larger samples and over more extended periods in different
populations are warranted to understand the associations between glucose abnormalities
and periodontitis.
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